Percutaneously injectable, radiopaque barium-based targets were acutely safe, targetable and treatable on CBCT and did not alter histotripsy treatment zone size in vivo.
Falk et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: